Salivary lactate dehydrogenase (LDH) as a tool for early diagnosis of oral cancer in individuals with Fanconi Anemia
Currently one of the greater challenges is the diagnosis and treatment of cancer. Many studies address the genetic and metabolic aspects to support in early diagnosis and increase the survival of individuals at high risk. Individuals with Fanconi anemia can be included in this high risk group because they have a predisposition to develop head and neck cancer. The use of salivary enzymes as biomarkers to detect the changes in oral tissue at the initial phase seems viable, because saliva is easy to obtain, it moisture oral mucosa and cells metabolic compounds can be found on it.
Source: Medical Hypotheses - Category: Biomedical Science Authors: Talita Piassa Mafessoni, Carol Eurich Mazur, Jos é Miguel Amenábar Source Type: research
More News: Anemia | Biomedical Science | Cancer | Cancer & Oncology | Faconi Anemia | Genetics | Head and Neck Cancer | Oral Cancer | Study